52 78c, as a highly specific and effective CD38 inhibitor, can reverse age-associated NAD + reduction and improve some metabolic and physiological parameters of aging, such as glucose tolerance, cardiac function, muscle function and exercise capacity in both natural aging and accelerated aging mice models
New extended-release formulations (lasting 2-4 weeks per injection) are in Phase III trials
Your care team can suggest a schedule that fits you
Evid Based Complement Altern Med 2016:8246171 Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology and pharmacology
Rajguru emphasizes individualized treatment planning, helping patients r ecover from injury, surgery, or gastrointestinal problems while restoring balance to their overall health